TAMOXIFEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tamoxifen, and when can generic versions of Tamoxifen launch?
Tamoxifen is a drug marketed by Actavis Labs Fl Inc, Aegis Pharms, Apotex, Dr Reddys Labs Sa, Eugia Pharma, Ivax Sub Teva Pharms, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms. and is included in twelve NDAs.
The generic ingredient in TAMOXIFEN is tamoxifen citrate. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tamoxifen
A generic version of TAMOXIFEN was approved as tamoxifen citrate by ACTAVIS LABS FL INC on February 20th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TAMOXIFEN?
- What are the global sales for TAMOXIFEN?
- What is Average Wholesale Price for TAMOXIFEN?
Summary for TAMOXIFEN
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for TAMOXIFEN |
| DailyMed Link: | TAMOXIFEN at DailyMed |



